51. Beta-galactosidase-responsive synthetic biomarker for targeted tumor detection
- Author
-
Sho Tabata, Tatsuya Nishihara, Satoshi Kuno, Masaru Tomita, Shinsuke Sando, Shinji Fukuda, Tomoyoshi Soga, Natsumi Saito, and Hiroshi Nonaka
- Subjects
02 engineering and technology ,010402 general chemistry ,01 natural sciences ,Catalysis ,Tumor Biomarkers ,Mice ,Antigen ,Antigens, Neoplasm ,Cell Line, Tumor ,Neoplasms ,Materials Chemistry ,Biomarkers, Tumor ,Medicine ,Animals ,Humans ,Beta-galactosidase ,Acetaminophen ,biology ,Staining and Labeling ,business.industry ,digestive, oral, and skin physiology ,Metals and Alloys ,General Chemistry ,021001 nanoscience & nanotechnology ,beta-Galactosidase ,0104 chemical sciences ,Surfaces, Coatings and Films ,Electronic, Optical and Magnetic Materials ,Tumor detection ,Ceramics and Composites ,Cancer research ,biology.protein ,Biomarker (medicine) ,0210 nano-technology ,business - Abstract
Tumor biomarkers are highly desirable for the screening of patients with a risk of tumor development and progression. Here, we report a beta-galactosidase (β-gal)-responsive acetaminophen (β-GR-APAP) as a synthetic plasma biomarker for targeted tumor detection. Tumor β-gal labeling via the recognition of tumor-related antigen enabled the detection of a tumor using β-GR-APAP.
- Published
- 2018